Ambitious study started at Gustave Roussy

26th June 2019

The Histolog Scanner is used on several hundreds of breast cancer surgical specimens involving breast surgeons and pathologists.

This international study takes place at Gustave Roussy in Villejuif (Paris – France) and involves physicians from this renowned center and from other centers in Reggio Emilia (Italy), Utrecht (The Netherlands) and Lausanne (Switzerland).

Gustave Roussy is one of the world’s leading cancer-research institutes and the premier European Cancer Centre. More information on Gustave Roussy here.

Previous
Previous

Participation to the IABS "Innovations and Advances in Breast Surgery" Conference

Next
Next

Promising results on breast biopsies published